HomeNewsBusinessReal EstateSubvention scheme a ticking time bomb: Mumbai real estate set to get taste of crisis like Noida

Subvention scheme a ticking time bomb: Mumbai real estate set to get taste of crisis like Noida

A clash between a betrayed home buyer, an abandoned lender and a cash-strapped developer is imminent.

May 07, 2020 / 13:37 IST
Story continues below Advertisement

Khyati Shah purchased an apartment in Raj Infinia in Mumbai. The transaction was executed for a price of Rs 1.98 crore in 2013 through a subvention scheme wherein the developer was liable to pay the pre-EMI till possession of the flat. From March 2019 however, the developer, Rajesh Lifespaces, stopped making its payments while not giving possession of the apartment to the home buyer. The bank, ICICI Bank, thereafter started sending demand letters to Khyati for making the pre-EMI payment. The matter went to the regulator. RERA, on January 8, 2020, ruled in favour of the home buyer and asked the bank to deal directly with the developer for the pending payments. Meanwhile, the project is stalled.

The reason I mention this case is to highlight a phenomenon that is poised to torment an already battered real estate market – the unravelling of subvention schemes. Developers who took responsibility of making pre-EMI payments on behalf of the home buyer and who will be unable to do so due to lack of sales. And projects will get stalled.

Story continues below Advertisement

What are subvention schemes? Loosely put it’s a tripartite agreement between builder, buyer and a bank wherein:

Step 1) A buyer books an apartment with a small down-payment in an under-construction project.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show